Constellium SE
NYSE:CSTMAluminum
+$0.32 today
- Market cap
- $2.88B
- Beta
- 1.54
- P/E (TTM)
- 10.7
- EPS (TTM)
- $3.17
Volume 1.46M
Average 2.27M
CSTM Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Constellium SENYSE: CSTM
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization declines year over year
Q3 FY2026 depreciation & amortization of $82M fell 2.4% year over year. Sequentially, it fell 2.4% from the prior quarter. Over 3 fiscal years it compounded at +4.8% a year.
Context
- Depreciation & amortization amounted to 3.9% of revenue in FY2025, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
Mixed currencies · from the cash flow
- Latest · FY2025
- 330M USD
- Year-over-year change
- —
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 330M | — |
| FY2024 | 2024-12-31 | 293.57M | +6.7% |
| FY2023 | 2023-12-31 | 275.07M | -4.2% |
| FY2022 | 2022-12-31 | 287M | -5.1% |
| FY2021 | 2021-12-31 | 302.3M | — |
Depreciation & Amortization vs competitors
How CSTM compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Depreciation & amortization amounts to 3.3% of revenue for CSTM, versus a peer median of 6.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$4.3B BRL | +10.5% | +12.3% | 9.7% | |
| FY2026 | ZAR 508.01M ZAR | +10.6% | +32.7% | 4.7% | |
| LTM Jun 2026 | $498.8M USD | -4.4% | -4.5% | 7.4% | |
| LTM Sep 2026 | $335M USD | — | +4.8% | 3.3% | |
| LTM Jun 2026 | $191M USD | -33.2% | -0.6% | 10.4% | |
| LTM Jun 2026 | $189.11M USD | +2.0% | +4.4% | 16.0% | |
| LTM Sep 2026 | $169.42M USD | +7.6% | +15.9% | 2.6% | |
| LTM Jun 2026 | $166.31M USD | +94.2% | +33.4% | 15.9% | |
| LTM Jun 2026 | $122.9M USD | +4.0% | +4.6% | 3.0% | |
| LTM Sep 2026 | $91.1M USD | +15.9% | +7.7% | 3.0% | |
| LTM Jul 2026 | $72.64M USD | +3.7% | +8.9% | 3.5% | |
| Peer median (excluding CSTM) | — | +5.8% | +8.3% | 6.1% | |
Competitors are the stored peer set for CSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 · EUR | FY2022 Dec 2022 · EUR | FY2023 Dec 2023 · EUR | FY2024 Dec 2024 · EUR | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Net Income | 296.64M | 316.34M | 152M | 54.08M | 272.92M |
| Depreciation & Amortization | 302.3M | 287M | 275.07M | 293.57M | 330M |
| Deferred Income Tax | 55M | (133.47M) | 75M | 72.43M | 0 |
| Stock-Based Compensation | 15M | 0 | 0 | 0 | 0 |
| Change in Working Capital | (261M) | (90.38M) | (119M) | (181.55M) | (222.93M) |
| Accounts Receivables | (227M) | 162.9M | (37M) | (48.29M) | (202.94M) |
| Inventory | (435M) | (253.28M) | 202M | (23.18M) | (148.95M) |
| Accounts Payables | 396M | 43.09M | (206M) | (38.63M) | 167.95M |
| Other Working Capital | 5M | (43.09M) | (78M) | (71.46M) | (38.99M) |
| Other Non-Cash Items | (50.94M) | 93.45M | 48.93M | 52.15M | 108.87M |
| Operating Cash Flow | 357M | 472.94M | 432M | 290.68M | 488.85M |
| Capital Expenditures | (232M) | (286.92M) | (366M) | (398.83M) | (329.9M) |
| Acquisitions (Net) | 9.36M | 2.1M | 49M | 9.66M | 11M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 1.64M | (1.05M) | 98M | 82.08M | 3M |
| Investing Cash Flow | (221M) | (285.87M) | (219M) | (307.09M) | (315.9M) |
| Debt Repayment | (377M) | (126.12M) | (166M) | 13.52M | (60.98M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (76.29M) | (114.96M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (58M) | (42.04M) | (8M) | 8.69M | (31.99M) |
| Financing Cash Flow | (435M) | (168.16M) | (174M) | (54.08M) | (207.94M) |
| Effect of Forex Changes | 7M | (8.92M) | 6.84M | (8.69M) | 14M |
| Net Change in Cash | (292M) | 10M | 45.84M | (79.19M) | (20.99M) |
| Free Cash Flow | 125M | 186.02M | 66M | (108.16M) | 158.95M |
Constellium SE
NYSE:CSTM
Intrinsic Alpha fair value
Locked
Current Price
$21.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.